Initiation of insulin pump therapy within 6 months of diagnosis of childhood type 1 diabetes was associated with reduced cardiovascular risk, particularly lower mean systolic blood pressure and higher high-density lipoprotein cholesterol (HDL-C), compared with those who initiated CSII within 2 – 3 years of disease onset (140). This evidence concerns the gene INS and type 1 diabetes mellitus.